The use of melatonin as a vaccine agent

Vaccine

Volumn 23, Issue 46-47, 2005, Pages 5321-5327

  Regodón, Sergio ^a   Martín Palomino, Pedro ^a   Fernández Montesinos, Rafael ^b   Herrera, Juan Luis ^b   Carrascosa Salmoral, M Pilar ^b   Píriz, Segundo ^a   Vadillo, Santiago ^a   Guerrero, Juan M ^b   Pozo, David ^b  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Dichelobacter nodosus; Immunomodulator; Melatonin

Indexed keywords

ALUMINUM HYDROXIDE; BACTERIAL VACCINE; IMMUNOLOGICAL ADJUVANT; MELATONIN; MELOVINE; REHYDRAGEL;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DICHELOBACTER NODOSUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOTROT; GRAM NEGATIVE INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMPLANT; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SHEEP DISEASE; SLOW RELEASE FORMULATION; TH2 CELL; TREATMENT OUTCOME; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AGGLUTINATION TESTS; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIOXIDANTS; BACTERIAL VACCINES; DRUG IMPLANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT ROT; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; MELATONIN; SHEEP; SHEEP DISEASES; VACCINATION;

EID: 27644576845     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.003     Document Type: Article

References (50)

1. Pink JR, Kieny MP. In Proceedings of the 4th meeting on Novel Adjuvants Currently in/close to Human Clinical Testing World Health Organization - Organisation Mondiale de la Sante Fondation Merieux, Annecy, France, 23-25, June 2003, Vaccine 2004;22(17-18):2097-102.
2. MM. Levine, and M.B. Sztein Vaccine development strategies for improving immunization: the role of modern immunology Nat Immunol 5 5 2004 460 464
3. W.R. Santos, V.M. de Lima, E.P. de Souza, R.R. Bernardo, M. Palatnik, and C.B. Palatnik de Sousa Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis Vaccine 21 1-2 2002 30 43
4. C.R. Kensil, U. Patel, M. Lennick, and D. Marciani Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex J Immunol 146 2 1991 431 437
5. M.J. McCluskie, and R.D. Weeratna Novel adjuvant systems Curr Drug Targets Infect Disord 1 3 2001 263 271
6. W.G. Degen, T. Jansen, and V.E. Schijns Vaccine adjuvant technology: from mechanistic concepts to practical applications Expert Rev Vaccines 2 2 2003 327 335
7. M.I. Masana, and M.L. Dubocovich Melatonin receptor signaling: finding the path through the dark Science's STKE 107 2001 39
8. J.M. Guerrero, and R.J. Reiter Melatonin-immune system relationships Curr Top Med Chem 2 2 2002 167 179
9. D. Pozo, M. Delgado, J.M. Fernandez-Santos, J.R. Calvo, R.P. Gomariz, and I. Martin-Lacave Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen FASEB J 11 1997 466 473
10. A. Carrillo-Vico, J.R. Calvo, P. Abreu, P.J. Lardone, S. Garcia-Maurino, and R.J. Reiter Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance FASEB J. 2004 03-0694fje
11. D. Pozo, R.J. Reiter, J.R. Calvo, and J.M. Guerrero Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin J Cell Biochem 65 1997 430 442
12. M. Gonzalez-Haba, S. García-Mauriño, J. Calvo, R. Goberna, and J. Guerrero High-affinity binding of melatonin by human circulating T lymphocytes (CD4+) FASEB J 9 1995 1331 1335
13. L. Finocchiaro, V. Nahmod, and J. Launay Melatonin biosynthesis and metabolism in peripheral blood mononuclear leukocytes Biochem J 280 1991 727 731
14. D. Pozo, S. García-Mauriño, J.M. Guerrero, and J.R. Calvo mRNA expression of nuclear receptor RZR/ROR, melatonin membrane receptor MT1, and hydroxyndole-O-methyltransferase in different populations of human immune cells J Pineal Res 37 2004 48 54
15. S. Garcia-Maurino, M.G. Gonzalez-Haba, J.R. Calvo, M. Rafii-El-Idrissi, V. Sanchez-Margalet, and R. Goberna Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes J Immunol 159 2 1997 574 581
16. S. Garcia-Maurino, D. Pozo, A. Carrillo-Vico, JR. Calvo, and J.M. Guerrero Melatonin activates Th1 lymphocytes by increasing IL-12 production Life Sci 65 20 1999 2143 2150
17. P. Barret, G. Davidson, D. Hazlerigg, M. Morris, A. Ross, and P. Morgan Mel 1a melatonin receptor expression is regulated by protein kinase C and an additional pathway addressed by the protein kinase C inhibitor Ro 31-8220 in ovine pars tuberalis cells Endocrinology 139 1998 163 171
18. A. Carrillo-Vico, S. Garcia-Maurino, J.R. Calvo, and J.M. Guerrero Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor FASEB J 17 6 2003 755 757
19. A. Carrillo-Vico, P.J. Lardone, J.M. Fernandez-Santos, I. Martin-Lacave, J.R. Calvo, and M. Karasek Human lymphocyte-synthesized melatonin is involved in the regulation of the IL-2/IL-2 receptor system J Clin Endocrinol Metab 2004 jc.2004-1429
20. M. Singh, and D. O'Hagan Advances in vaccine adjuvants Nat Biotechnol 17 11 1999 1075 1081
21. M. Karasek, R.J. Reiter, D.P. Cardinali, and M. Pawlikowski Future of melatonin as a therapeutic agent Neuro Endocrinol Lett 23 Suppl. 1 2002 118 121
22. J.C. Thiery, and B. Malpaux Seasonal regulation of reproductive activity in sheep: modulation of access of sex steroids to the brain Ann NY Acad Sci 1007 2003 169 175
23. J.R. Egerton, and I.M. Parsonson Isolation of Fusiformis nodosus from cattle Aust Vet J 42 11 1966 425 429
24. R.M. Kennan, O.P. Dhungyel, R.J. Whittington, J.R. Egerton, and J.I. Rood The Type IV fimbrial subunit gene (fimA) of Dichelobacter nodosus is essential for virulence, protease secretion, and natural competence J Bacteriol 183 15 2001 4451 4458
25. M.E. Katz, P.M. Howarth, W.K. Yong, G.G. Riffkin, L.J. Depiazzi, and J.I. Rood Identification of three gene regions associated with virulence in Dichelobacter nodosus, the causative agent of ovine footrot J Gen Microbiol 137 9 1991 2117 2124
26. O.P. Dhungyel, R.J. Whittington, and J.R. Egerton Serogroup specific single and multiplex PCR with pre-enrichment culture and immuno-magnetic bead capture for identifying strains of D. nodosus in sheep with footrot prior to vaccination Mol Cell Probes 16 4 2002 285 296
27. J.R. Egerton, L.A. Ribeiro, P.J. Kieran, and C.M. Thorley Onset and remission of ovine footrot Aust Vet J 60 11 1983 334 336
28. R.J. Whittington, and P.J. Nicholls Grading the lesions of ovine footrot Res Vet Sci 58 1 1995 26 34
29. KA. Abbott, and J.R. Egerton Effect of climatic region on the clinical expression of footrot of lesser clinical severity (intermediate footrot) in sheep Aust Vet J 81 12 2003 756 762
30. KA. Abbott, and C.J. Lewis Current approaches to the management of ovine footrot Vet J 169 1 2005 28 41
31. T. Glynn Benign footrot - an epidemiological investigation into the occurrence, effects on production, response to treatment and influence of environmental factors Aust Vet J 70 1 1993 7 12
32. J.R. Egerton, P.T. Cox, B.J. Anderson, C. Kristo, M. Norman, and J.S. Mattick Protection of sheep against footrot with a recombinant DNA-based fimbrial vaccine Vet Microbiol 14 4 1987 393 409
33. J.D. Hunt, D.C. Jackson, P.R. Wood, D.J. Stewart, and L.E. Brown Immunological parameters associated with antigenic competition in a multivalent footrot vaccine Vaccine 13 17 1995 1649 1657
34. P. Martin-Palomino, S. Piriz, R. Jimenez, F.J. Serrano, and S. Vadillo Effectiveness of different adjuvants in stimulating Dichelobacter nodosus antibody in sheep vaccinated against ovine footrot Acta Vet Hung 52 3 2004 275 285
35. M.A. Hurtado, S. Piriz, J. Valle, R. Jimenez, and S. Vadillo Aetiology of ovine footrot in Spain Vet Rec 142 3 1998 60 63
36. R.D. Lewis, H.H. Meyer, J.L. Gradin, and A.W. Smith Effectiveness of vaccination in controlling ovine footrot J Anim Sci 67 5 1989 1160 1166
37. B. Hosie Footrot and lameness in sheep Vet Rec 154 2 2004 37 38
38. C. Viguie, A. Caraty, A. Locatelli, and B. Malpaux Regulation of luteinizing hormone-releasing hormone (LHRH) secretion by melatonin in the ewe. I. Simultaneous delayed increase in LHRH and luteinizing hormone pulsatile secretion Biol Reprod 52 5 1995 1114 1120
39. B. Malpaux, H. Tricoire, F. Mailliet, A. Daveau, M. Migaud, and D.C. Skinner Melatonin and seasonal reproduction: understanding the neuroendocrine mechanisms using the sheep as a model Reprod Suppl 59 2002 167 179
40. J.W. Mannhalter, H.O. Neychev, G.J. Zlabinger, R. Ahmad, and M.M. Eibl Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation Clin Exp Immunol 61 1 1985 143 151
41. C. Pioli, M.C. Caroleo, G. Nistico, and G. Doria Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation Int J Immunopharmacol 15 4 1993 463 468
42. M.C. Caroleo, G. Doria, and G. Nistico Melatonin restores immunodepression in aged and cyclophosphamide-treated mice Ann NY Acad Sci 719 1994 343 352
43. J.M. Brewer, M. Conacher, C.A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling J Immunol 163 12 1999 6448 6454
44. R.T. Kenney, D.L. Sacks, J.P. Sypek, L. Vilela, A.A. Gam, and K. Evans-Davis Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis J Immunol 163 8 1999 4481 4488
45. G. Nunnari, L. Nigro, F. Palermo, D. Leto, R.J. Pomerantz, and B. Cacopardo Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels Infection 31 6 2003 379 382
46. N. Petrovsky, and L.C. Harrison Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol 158 11 1997 5163 5168
47. J. Barchas, F. DaCosta, and S. Spector Acute pharmacology of melatonin Nature 214 91 1967 919 920
48. G.A. Bubenik Gastrointestinal melatonin: localization, function, and clinical relevance Dig Dis Sci 47 10 2002 2336 2348
49. I.M. Kvetnoy, I.E. Ingel, T.V. Kvetnaia, N.K. Malinovskaya, S.I. Rapoport, and N.T. Raikhlin Gastrointestinal melatonin: cellular identification and biological role Neuro Endocrinol Lett 23 2 2002 121 132
50. P. Sileri, G.S. Sica, P. Gentileschi, M. Venza, D. Benavoli, and T. Jarzembowski Melatonin reduces bacterial translocation after intestinal ischemia-reperfusion injury Transplant Proc 36 10 2004 2944 2946